Structure of 5-formyltetrahydrofolate cyclo-ligase from Bacillus anthracis (BA4489) by Meier, Christoph et al.
protein structure communications
168 doi:10.1107/S1744309107007221 Acta Cryst. (2007). F63, 168–172
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
Structure of 5-formyltetrahydrofolate cyclo-ligase
from Bacillus anthracis (BA4489)
Christoph Meier,
a,b Lester G.
Carter,
a Graeme Winter,
c Ray J.
Owens,
a David I. Stuart
a,b and
Robert M. Esnouf
a,b*
aOxford Protein Production Facility, The Henry
Wellcome Building for Genomic Medicine,
Oxford University, Roosevelt Drive,
Oxford OX3 7BN, England,
bDivision of
Structural Biology, The Henry Wellcome
Building for Genomic Medicine, Oxford
University, Roosevelt Drive, Oxford OX3 7BN,
England, and
cCCLRC Daresbury Laboratory,
Warrington, Cheshire WA4 4AD, England
Correspondence e-mail: robert@strubi.ox.ac.uk
Received 21 December 2006
Accepted 12 February 2007
PDB Reference: 5-formyltetrahydrofolate cyclo-
ligase, 2jcb, r2jcbsf.
Bacillus anthracis is a spore-forming bacterium and the causative agent of the
disease anthrax. The Oxford Protein Production Facility has been targeting
proteins from B. anthracis in order to develop high-throughput technologies
within the Structural Proteomics in Europe project. As part of this work, the
structure of 5-formyltetrahydrofolate cyclo-ligase (BA4489) has been deter-
mined by X-ray crystallography to 1.6 A ˚ resolution. The structure, solved in
complex with magnesium-ion-bound ADP and phosphate, gives a detailed
picture of the proposed catalytic mechanism of the enzyme. Chemical
differences from other cyclo-ligase structures close to the active site that could
be exploited to design speciﬁc inhibitors are also highlighted.
1. Introduction
The Oxford Protein Production Facility (OPPF) was established to
develop methods for high-throughput protein production and crys-
tallization. As part of these developments, a pilot project was
undertaken to study 48 proteins from Bacillus anthracis, focusing on
protein families that are well conserved across a wide range of
bacteria. The causative agent of anthrax, B. anthracis is a large Gram-
positive spore-bearing bacterium. Sequencing of the genome of the
B. anthracis Ames strain (Read et al., 2003) revealed two plasmids,
pXO1 and pXO2, that carry the major virulence factors, as well as
5.23 megabases of normal chromosomal DNA predicted to code for
about 5311 genes. The set of proteins chosen for this study (Au et al.,
2006) are all encoded by the chromosomal DNA.
Folate, a water-soluble B vitamin discovered in the 1940s, is a
required cofactor for cell growth in all organisms and is synthesized
by plants, prokaryotes and yeast. It acts a carrier of one-carbon
groups and is necessary for the synthesis of DNA and RNA precur-
sors as well as for methionine biosynthesis. In the cell, folic acid exists
as a family of cofactors with different oxidation states [folate, di-
hydrofolate (DHF) and tetrahydrofolate (THF)]; the one-carbon
units carried by these cofactors can also have different oxidation
states (methanol to formate) which are enzymatically inter-
convertable. These different forms of THF donate or accept one-
carbon units in a range of metabolic reactions (the so-called one-
carbon metabolism), which include the de novo synthesis of purines
and thymidylate (methylation of dUMP to give dTMP) and the
remethylation of homocysteine to methionine [methionine can
subsequently be adenylated to form S-adenosylmethionine (SAM),
itself a cofactor and one-carbon donor for numerous other methy-
lation reactions]. An overview of bacterial folate metabolism is given
in Fig. 1(a).
5-Formyl-THF is a member of the folate cofactor family. However,
it is not used directly as a one-carbon donor, but instead acts as a
regulator of folate metabolism (Stover & Schirch, 1991; Bertrand &
Jolivet, 1989). The enzyme 5-formyl-THF cyclo-ligase (also known as
5,10-methenyltetrahydrofolate synthetase; MTHFS) has a scavenger
role as the only enzyme that acts on 5-formyl-THF, converting it to
5,10-methenyl-THF in an ATP- and Mg
2+-dependent reaction
(Fig. 1b). The product is then converted into other reduced folates
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All rights reservedinvolved in one-carbon metabolism (Chen et al., 2004). Since
5-formyl-THFacts as an inhibitor of other folate-dependent enzymes,
5-formyl-THF cyclo-ligase may also indirectly regulate several key
metabolic processes, such as purine, pyrimidine and amino-acid
biosynthesis (Stover & Schirch, 1991; Bertrand & Jolivet, 1989). Since
all of these processes are required for cell growth and development,
5-formyl-THF cyclo-ligase has been suggested as a target for drug
discovery (Jolivet et al., 1996).
2. Materials and methods
Cloning, expression and protein puriﬁcation followed standard OPPF
pipeline protocols, as described previously (Ren et al., 2005; Alzari et
al., 2006). Brieﬂy, the 5-formyl-THF cyclo-ligase gene (BA4489) was
ampliﬁed from genomic DNA by PCR with the forward primer
ggggacaagtttgtacaaaaaagcaggcttcgaaggagatagaaccatggcacatcaccacca-
ccatcacGTGAGAGAAGAGAAGCTACGTTTACGTAAAC and
the reverse primer ggggaccactttgtacaagaaagctgggtctcaCTATACAA-
GCCCATTTTTAACCATTGTTCC incorporating a ribosome-
binding site and an N-terminal hexahistidine tag. The gene was then
inserted into the expression vector pDEST14 using Gateway
recombinatorial cloning (Invitrogen), resulting in an expressed
protein in which the N-terminal methionine residue is replaced by an
uncleavable puriﬁcation tag MAHHHHHHV–. The expression
vector was transformed into Escherichia coli (strain Rosetta pLysS)
and expression was induced by the addition of 0.5 mM isopropyl
 -d-thiogalactopyranoside (IPTG). The protein was puriﬁed by a
combination of Ni–NTA afﬁnity chromatography and gel ﬁltration.
Crystallization trials and optimizations were carried out using the
nanodrop crystallization procedure with standard OPPF protocols
(Walter et al., 2003, 2005). In the absence of cofactors, 5-formyl-THF
cyclo-ligase gave crystals of up to 160   160   80 mm in size which
diffracted to medium resolution (anisotropically to 3.0 A ˚ at best;
space group P42212; data not shown). However, in the presence of
ATP, Mg
2+ and folinate cofactors, one larger (380   220   60 mm)
and better ordered crystal was obtained. This grew within 5 d in
200 nl sitting drops containing 5.5 mg ml
 1 puriﬁed protein, 3.8 mM
folinate, 3.8 mM ATP, 30 mMMgCl2, 12.5% polyethylene glycol 3350,
50 mM bis-Tris pH 5.5 equilibrated against a reservoir solution of
25% polyethylene glycol 3350, 100 mM bis-Tris pH 5.5. Crystals were
cryoprotected in a mixture containing 20% glycerol and 80% reser-
voir solution and ﬂash-cooled in liquid nitrogen (100 K).
The crystal of 5-formyl-THF cyclo-ligase grown in the presence of
ATP and folinate diffracted well, with measurements extending to
Bragg spacings of 1.5 A ˚ . Diffraction data were recorded (at the ESRF
synchrotron, beamline ID14-EH1) in two passes: a high-resolution
pass of 362 images was initially recorded using 0.5  oscillations, 6 s
exposures and a crystal-to-detector distance of 114 mm, followed by a
low-resolution pass of 113 images using 2  oscillations, 2 s (the ﬁrst 21
images) or 1 s exposures and a crystal-to-detector distance of
286 mm. However, processing these images using either DENZO or
MOSFLM was initially problematic owing to scaling problems that
we attribute to a high mosaic spread (Bahar et al., 2006. In DENZO,
reﬁning the mosaicity proved unstable and the most plausible
processing was obtained using a ﬁxed mosaicity of 1.5 , while with
MOSFLM the reﬁned mosaicity varied between 1.2 and 4 . As part of
a crystallographic workshop, the diffraction data were reprocessed
using the program XDS (Kabsch, 1993), which yielded an improved
data set with a mosaicity of 0.6  (using the XDS deﬁnition; see Table 1
and Bahar et al., 2006 for more details). Eventually, the structure was
solved using the program MOLREP (Vagin & Teplyakov, 1997) with
the crystal structure of a homologue from B. subtilis (Yqgn) as a
search model (PDB code 1ydm;  40% sequence identity). Based on
the molecular-replacement solution, the program ARP/wARP
(Perrakis et al., 1999) was used to automatically build the structure
and carry out ligand ﬁtting. Manual rebuilding used Coot (Emsley &
Cowtan, 2004) and REFMAC (Murshudov et al., 1999) was employed
to perform TLS reﬁnement (using each chain as a separate body)
using isotropic B-factor reﬁnement and weak restraints between
main-chain atoms of the two chains. Crystallographic statistics are
shown in Table 1. The structure was analysed using PROCHECK
(Laskowski et al., 1993) and MolProbity (Lovell et al., 2003). Struc-
ture superpositions were calculated using SHP (Stuart et al., 1979).
Figures were prepared using BobScript (Esnouf, 1997) and PyMOL
(DeLano, 2002).
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Figure 1
Folate metabolism and the role of 5-formyl-THF cyclo-ligase. (a) An overview of bacterial folate metabolism (modiﬁed from Zittoun & Zittoun, 1972). Both folate and the
one-carbon group it carries can exist in different oxidation states, which are interconvertable. The different forms of folate play a role in several important metabolic
pathways, including the biosynthesis of purines, methionine and thymidylate. (b) The reaction converting 5-formyl-THF (top) to 5,10-methenyl-THF (bottom) that is
catalysed by 5-formyl-THF cyclo-ligase. The metabolically important one-carbon group carried by 5-formyl-THF is highlighted in grey. The catalytically important N5 and
N10 positions are labelled.3. Results and discussion
The structure of 5-formyl-THF cyclo-ligase (Fig. 2) forms a single
domain with an  +  fold: a central layer of mixed (parallel and
antiparallel)  -sheet ﬂanked by helices on either side. This fold
belongs to the NagB/RpiA/CoA transferase-like superfamily of
enzymes (Murzin et al., 1995), the members of which are involved in a
diverse range of metabolic processes but share the common property
of phosphate binding.
The crystal structure comprises two protein chains in the
crystallographic asymmetric unit. Both chain traces are continuous
and include parts of the hexahistidine puriﬁcation tag (the A chain
extends from residue  4 to 189 and the B chain from  1 to 188). The
conformations of the two chains are nearly identical [a root-mean-
square deviation (r.m.s.d.) between C -atom positions of 0.39 A ˚ for
residues 1–188 in each chain], but the electron density for the A chain
is of somewhat better quality and the discussion focuses on this chain.
It has been suggested that 5-formyl-THF cyclo-ligase forms dimers
in solution and that this oligomeric state is related to the cooperative
binding of its substrate 5-formyl-THF (Chen et al., 2005). While the
structure presented here is, in principle, consistent with a dimeric
protein, an analysis (using PISA; Krissinel & Henrick, 2005) suggests
that no biologically signiﬁcant interfaces are present in our structure.
All the potential interface regions in the crystal consist exclusively of
hydrogen bonds and salt bridges and the largest possible interface
area comprises only 500 A ˚ 2 ( 5% of the total surface of the protein
monomer), which is signiﬁcantly less than for most biological dimers
(Lesk, 2004). However, it is conceivable that dimerization occurs
transiently in solution, especially at higher concentrations (Chen et
al., 2005).
The structure of B. anthracis 5-formyl-THF cyclo-ligase was
obtained by cocrystallization with folinate, ATP and Mg
2+.T h e
structure shows a pocket in the protein containing a bound nucleotide
cofactor (Fig. 3a). Interestingly, the ATP molecule which was present
in the crystallization experiment has been hydrolysed to ADP and
inorganic phosphate. The high-resolution map shows clear and
separated electron density for these moieties separated by a water
molecule. The conformation of the ADP  - and  -phosphates is
stabilized as part of an octahedral Mg
2+ coordination shell (Fig. 3b).
There issome weak ill-deﬁned electron density in the region expected
to be occupied by the substrate and/or product, but it is not of
sufﬁcient quality to allow it to be built. However, ATP/ADP only
occupies as small part of the active-site pocket, adjacent to a wider
cavity which could accommodate the pteridine ring of folinate.
Furthermore, this cavity is lined by a number of hydrogen-bond
donors and acceptors, as well as hydrophobic residues, a suitable
environment for binding a heterocyclic aromatic ring (Fig. 3a).
Our ﬁndings support a catalytic mechanism in which 5-formyl-THF
interacts directly with the  -phosphate of the ATP cofactor and
thereby allows the formation of the azoline ring in the substrate.
Based on NMR-labelling studies, a catalytic mechanism has been
proposed in which 5-formyl-THF becomes transiently phosphoryl-
ated by ATP to form a phospho-enol intermediate (Chen et al., 2005;
Fig. 3c), which is entirely consistent with our observations. Based on
this scheme, our crystal structure would represent the ﬁnal stage of
the catalytic mechanism, after the enzyme has turned over and
released the product.
At present, structures are available for two homologues of
B. anthracis 5-formyl-THF cyclo-ligase, those from Mycoplasma
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Table 1
Crystallographic data-collection and processing statistics.
Values in parentheses are for the outer resolution shell.
Data collection
Experiment type Single wavelength
Beamline ESRF ID14-EH1
Wavelength (A ˚ ) 0.934
Data processing
Resolution limits (A ˚ ) 20–1.6 (1.69–1.60)
Unique reﬂections 49797 (7241)
Space group P1
Unit-cell parameters (A ˚ ,  ) a = 37.15, b = 45.50, c = 67.00,
  = 74.9,   = 78.0,   = 70.1
Completeness (%) 95.5 (94.3)
Multiplicity 2.5 (2.0)
I/ (I) 13.1 (2.9)
Rmerge† 0.042 (0.341)
Reﬁnement statistics
Resolution limits (A ˚ ) 20–1.6 (1.64–1.60)
R factor 0.189 (0.280)
Free R factor (random 5% of reﬂections) 0.238 (0.346)
No. of non-H atoms (protein/cofactor/water) 3168/66/325
R.m.s.d. bond lengths (A ˚ ) 0.016
R.m.s.d. bond angles ( )1 . 6
Mean B value (A ˚ 2) 33.7
Ramachandran plot‡
Residues in allowed regions (%) 98.6
Residues in disallowed regions (%) 0.6
† Rmerge =
P
jI  h Iij=
P
hIi. ‡ Calculated using the program PROCHECK
(Laskowski et al., 1993).
Figure 2
Two orthogonal views of the secondary structure of B. anthracis 5-formyl-THF cyclo-ligase (coloured from blue at the N-terminus to red at the C-terminus). Secondary-
structural elements are labelled on the right-hand view. The ADP and phosphate cofactors are shown in a stick representation, with the Mg
2+ ion shown as a grey sphere.pneumoniae (PDB codes 1sbq, 1u3f and 1u3g; Chen et al., 2004, 2005)
and from Bacillus subtilis (PDB code 1ydm; unpublished work).
Sequence and structural alignments (Fig. 4) reveal only moderate
sequence similarities to the B. anthracis enzyme ( 25% and  40%
identity, respectively) but a high degree of structure conservation
(r.m.s.d. for C -atom superpositions of  1.1 A ˚ for 150 and 160
residues, respectively). These ﬁndings underscore the critical meta-
bolic function of the enzyme, for which there appears to be strongly
conservative evolutionary pressure. The B. anthracis and B. subtilis
sequences both contain a 20 amino-acid insertion compared with the
M. pneumoniae homologue (residues 93–112 in B. anthracis num-
bering). Structurally, this insertion lines part of the substrate-binding
site and, interestingly, it is positioned such that it precludes the
substrate-binding mode postulated for the M. pneumoniae structure
(PDB code 1u3g; Chen et al., 2005). However, we note that in the
model the atoms forming the portion of the substrate that impinges
on this insertion have been assigned occupancies of zero, suggesting
uncertainty in the interpretation. This difference, along with other
changes to the amino acids lining the site (particularly Thr50, Met53
and Tyr138; Fig. 4a) suggest that despite the structural similarity,
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Figure 3
The mechanism of catalysis by B. anthracis 5-formyl-THF cyclo-ligase. (a) A cut-
through of the 5-formyl-THF cyclo-ligase structure showing the cofactor/substrate-
binding pocket with bound ADP and phosphate. The enlarged view shows 2Fo   Fc
electron density contoured at 1.5  (green) for these moieties. Weak electron
density (not shown) suggests that the substrate/product binds in the right-hand side
of this pocket. (b) A ball-and-stick diagram showing the octahedral coordination of
the Mg
2+ ion by the  - and  -phosphates of ADP, residues Asp144 and Asp173 and
two tightly bound water molecules. Interaction distances are shown in A ˚ . This
coordination helps orient the  -phosphate of ATP correctly for attack on the
5-formyl-THF. The green lines show 2Fo   Fc electron density contoured at 2.2 .
(c) The proposed catalytic mechanism of B. anthracis 5-formyl-THF cyclo-ligase via
a phospho-enol intermediate. Our structure represents the ﬁnal stage of the
process, after the product has dissociated from the binding pocket.there is potential for designing inhibitors of 5-formyl-THF cyclo-
ligase that are speciﬁc to particular pathogen species.
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Figure 4
Sequence and structural alignments of prokaryotic 5-formyl-THF cyclo-ligase enzymes. (a) Annotated sequence alignment of the B. anthracis, B. subtilis and M. pneumoniae
5-formyl-THF cyclo-ligases. The residue numbering refers to the B. anthracis sequence, with secondary-structural assignments shown above the alignment. (b) Orthogonal
views of the superposition of the corresponding crystal structures (calculated using the program SHP; Stuart et al., 1979). The B. anthracis structure is shown in a red
semitransparent cartoon representation; the crystal structures for the B. subtilis (PDB code 1ydm) and M. pneumoniae (PDB code 1u3g) enzymes are shown as coloured C 
traces in blue and green, respectively. The overall fold of the protein is tightly conserved, except for the 20 amino-acid insertion at the bottom right of the right-hand ﬁgure.